Mark Forman

Mark Forman currently serves as the Chief Medical Officer at Passage Bio. Prior to this role, Mark held positions at various pharmaceutical companies such as Alzheimer's Drug Discovery Foundation, ACADIA Pharmaceuticals Inc., and Merck, specializing in Translational Medicine. With a background in Neuropathology, Mark has a strong academic history including degrees from Duke University School of Medicine, The Rockefeller University, and Yale University.